Hepatitis C OnlineLogo
Section Navigation
Common TitleNew Zealand Genotype 3 and 6 Trial
Official Title Efficacy of Ledipasvir and Sofosbuvir, with or without Ribavirin, for 12 Weeks inPatients with HCV Genotype 3 or 6 Infection
Phase Phase II
ClinicalTrials.gov NCT01826981
Treatments
Ledipasvir-Sofosbuvir

Ledipasvir-Sofosbuvir

Tradename:HarvoniOther Names:LDV-SOFClass:FDA-Approved
Funding
IndustryGilead Sciences

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.